GlassScriptPhysician profile
Catherine Graulich
NPI 1891579587
$1,306.65
in general payments reported to CMS, 2019-2025
19 companies · $1,091 in 2025
The $1,091 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $20.65 · 2024: $195 · 2025: $1,091.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,306.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $308.65 | 2024-2025 | |
| Axsome Therapeutics, INC. | $298.52 | 2024-2025 | Auvelity |
| Alkermes, INC. | $162.38 | 2024-2025 | Lybalvi, Aristada, Vivitrol |
| Vanda Pharmaceuticals INC. | $92.12 | 2025 | Fanapt |
| Corium, LLC | $87.11 | 2025 | Azstarys |
| Lundbeck LLC | $63.04 | 2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $42.14 | 2025 | Abilify Asimtufii, Abilify Maintena |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $41.51 | 2025 | Caplyta |
| Amgen INC. | $27.09 | 2024 | Otezla, Repatha |
| Janssen Pharmaceuticals, INC | $24.63 | 2024 | Spravato |
| Exact Sciences Corporation | $24.24 | 2024 | Cologuard Collection Kit |
| Halozyme INC | $20.65 | 2023 | |
| Collegium Pharmaceutical, INC. | $20.57 | 2025 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $17.76 | 2025 | Xyosted, Qelbree |
| Almatica Pharma LLC | $16.44 | 2025 | Loreev Xr |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $15.12 | 2025 | |
| Novo Nordisk INC | $15.07 | 2025 | Rybelsus, Ozempic |
| Acella Pharmaceuticals, LLC | $15.00 | 2024 | NP Thyroid 60 |
| Vertical Pharmaceuticals, LLC | $14.61 | 2024 | Relexxii |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Graulich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.